Phenerine 50 mg Sugar-coated tablet

    Phenerine 50 mg Sugar-coated tablet

    S4
    PDF Leaflet Revision Date: 08 December 1978


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of Parkinsonism.

    Dosage (summary)

    1-2 tablets twice to four times daily.

    Special Populations

    • Diabetes mellitus
    • Galactose intolerance

    Key Drug Interactions

    • Anticholinergic agents
    • Amantadine
    • Antihistamines
    • Butyrophenones
    • Phenothiazines
    • Tricyclic antidepressants

    Contraindications

    • Prostatic enlargement
    • Paralytic ileus
    • Pyloric stenosis
    • Closed-angle glaucoma

    Common side effects

    • Dry mouth
    • Thirst
    • Dilated pupils
    • Flushing
    • Bradycardia
    • Constipation

    Counselling Points

    • May cause dryness of mouth
    • Monitor for tachycardia
    • Avoid abrupt withdrawal

    Serious warnings

    • Gradual dosage increase required
    • Monitor for severe mental disturbances
    Important Disclaimer

    The Phenerine 50 mg Sugar-coated tablet professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn